发明名称 Hepatitis C inhibitor peptides
摘要 Disclosed is a compound of Formula (I), wherein a is 0 or 1; b is 0 or 1; Y is H or C1-6 alkyl; B is H, an acyl derivative or a sulphonyl derivative; W is hydroxy or a N-substituted amino; or a pharmaceutically acceptable salt or ester thereof. Such compounds are useful in the treatment of hepatitis C virus ( HCV ) infection.
申请公布号 NZ510395(A) 申请公布日期 2003.12.19
申请号 NZ19990510395 申请日期 1999.08.09
申请人 BOEHRINGER INGELHEIM (CANADA) LTD 发明人 TSANTRIZOS, YOULA S;LLINAS-BRUNET, MONTSE;BAILEY,MURRAY D;CAMERON, DALE;GHIRO, ELISE;GOUDREAU, NATHALIE;OUPART, MARC-ANDRE;RANCOURT, JEAN
分类号 C12N15/09;A61K31/13;A61K31/7052;A61K38/00;A61K38/21;A61K38/55;A61K45/00;A61P1/16;A61P31/12;A61P31/14;A61P43/00;C07K1/10;C07K5/10;C07K5/107;C07K7/06;C07K14/81;G01J5/20;G01V8/00;H01Q5/00;H01Q21/06;(IPC1-7):C07K14/81 主分类号 C12N15/09
代理机构 代理人
主权项
地址